EU's 4 China-reliant sectors face supply chain overhaul toward India

For supply chain and procurement executives, the EU's dependency on Chinese inputs is not an abstract geopolitical concern—it directly shapes supplier risk, lead times, and production continuity. The report highlights four sectors where China's grip is strongest: electronics, solar components, pharmaceuticals, and rare earths. India's expanding hubs in Tamil Nadu and Karnataka and its role as a major API supplier offer a credible second source.

The European Union's deepening reliance on Chinese supply chains has become a structural constraint on its strategic autonomy, according to a report circulated on September 10, 2026 by IANS and prokerala.com, citing Eurasia News. The central argument is that the United Kingdom has already begun the hard work of decoupling critical trade and investment flows from China by diversifying toward partners such as India, and that the EU should adopt a similar playbook. This is not framed as a sudden rupture but as a phased strategic recalibration aimed at reducing vulnerability in sectors where Chinese dominance is most pronounced. The report names electronics, solar components, pharmaceuticals, and rare earths as the areas where Europe's exposure remains far deeper than Britain's. The risk is not merely economic: policymakers worry that such dependence forces EU member states to soften criticism of Beijing on Taiwan, human rights, and trade disputes in order to protect essential input flows. China's demonstrated willingness to weaponize export controls, with tungsten cited as a recent example, has turned this theoretical concern into a concrete supply chain planning problem.

“

The European Union's deepening reliance on Chinese supply chains has become a structural constraint on its strategic autonomy, according to a report circulated on September 10, 2026 by IANS and prokerala.com, citing Eurasia News.

The UK's template is significant because it shows that a European economy can begin shifting supplier relationships without collapsing its industrial base. Britain's approach has involved building trade and investment ties with India and other alternative partners, allowing it to reduce its China exposure in a controlled manner. The report argues that India is the natural partner around which the EU should build its own diversification strategy. India's scale, workforce, and expanding industrial base position it to absorb a meaningful share of the dependency currently concentrated in China. In electronics, India's assembly and components ecosystem has grown rapidly, particularly around hubs such as Tamil Nadu and Karnataka. In pharmaceuticals, India is already a major supplier of active pharmaceutical ingredients, making it a credible second source for European drug manufacturers. The report's most operationally useful recommendation is to avoid attempting a wholesale overnight switch, which would be disruptive and impractical, and instead begin with a small number of carefully selected sectors where China's grip is strongest and where viable alternatives are already available.